When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Every year when my health insurance policy renews, I worry whether my private insurer will deny the treatments I need to live ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Olivia Petter talks to experts who say that people with eating disorders are especially vulnerable to the allure of ‘quick fix’ slimming with diabetes drug semaglutide... and are not thinking about it ...

Reforms of prescription drug pricing are finally taking full effect, just in time for Donald Trump and the Republicans to ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Olivia Petter, The Independent If someone had told my teenage self that a magical drug would make me thin, I’d have taken it ...